Raymond James & Associates Vaneck ETF Tr Vaneck Pharmaceu Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Raymond James & Associates holds 11,871 shares of PPH stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,871

Previous 12,195 2.66%

Holding current value

$1.1 Million

Previous $1.12 Million 1.17%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$90.59 - $99.43 $29,351 - $32,215	-324 Reduced 2.66%	11,871 $1.13 Million
Q2 2024 Jul 19, 2024	BUY	$84.87 - $93.23 $515,585 - $566,372	6,075 Added 99.26%	12,195 $1.12 Million
Q1 2024 Apr 22, 2024	BUY	$82.63 - $90.89 $95,437 - $104,977	1,155 Added 23.26%	6,120 $555,000
Q4 2023 Jan 16, 2024	BUY	$74.32 - $81.37 $5,796 - $6,346	78 Added 1.6%	4,965 $404,000
Q3 2023 Oct 24, 2023	BUY	$76.26 - $83.18 $61,008 - $66,544	800 Added 19.57%	4,887 $390,000
Q2 2023 Jul 25, 2023	SELL	$75.02 - $80.55 $196,477 - $210,960	-2,619 Reduced 39.05%	4,087 $321,000
Q1 2023 Apr 14, 2023	SELL	$73.68 - $79.63 $1.72 Million - $1.86 Million	-23,307 Reduced 77.66%	6,706 $520,000
Q4 2022 Feb 08, 2023	BUY	$67.31 - $79.26 $1.12 Million - $1.32 Million	16,613 Added 123.98%	30,013 $2.33 Million
Q3 2022 Oct 25, 2022	BUY	$66.73 - $77.98 $2,669 - $3,119	40 Added 0.3%	13,400 $901,000
Q2 2022 Aug 12, 2022	BUY	$72.65 - $83.96 $140,141 - $161,958	1,929 Added 16.88%	13,360 $1.03 Million
Q1 2022 May 11, 2022	BUY	$73.73 - $80.41 $84,347 - $91,989	1,144 Added 11.12%	11,431 $912,000
Q4 2021 Feb 08, 2022	BUY	$71.36 - $77.51 $734,080 - $797,345	10,287 New	10,287 $792,000
Q3 2021 Nov 02, 2021	SELL	$72.19 - $77.22 $260,533 - $278,686	-3,609 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$67.83 - $74.97 $813 - $899	-12 Reduced 0.33%	3,609 $264,000
Q1 2021 May 14, 2021	SELL	$66.06 - $71.06 $4,359 - $4,689	-66 Reduced 1.79%	3,621 $250,000
Q4 2020 Feb 12, 2021	SELL	$58.91 - $66.91 $35,346 - $40,146	-600 Reduced 14.0%	3,687 $245,000
Q2 2020 Jul 28, 2020	BUY	$52.32 - $64.28 $4,080 - $5,013	78 Added 1.85%	4,287 $267,000
Q1 2020 Apr 21, 2020	BUY	$47.54 - $67.62 $28,524 - $40,572	600 Added 16.63%	4,209 $229,000
Q4 2019 Feb 12, 2020	BUY	$54.75 - $64.76 $197,592 - $233,718	3,609 New	3,609 $232,000
Q2 2019 Aug 06, 2019	SELL	N/A	-5,100 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	N/A	-84,114 Reduced 94.28%	5,100 $279,000
Q3 2018 Nov 14, 2018	SELL	N/A	-2,292 Reduced 2.5%	89,214 $5.74 Million
Q2 2018 Aug 14, 2018	SELL	N/A	-769 Reduced 0.83%	91,506 $5.4 Million
Q1 2018 May 14, 2018	BUY	N/A	673 Added 0.73%	92,275 $5.24 Million
Q4 2017 Feb 14, 2018	BUY	N/A	3,087 Added 3.49%	91,602 $5.43 Million
Q3 2017 Nov 13, 2017	SELL	N/A	-9,011 Reduced 9.24%	88,515 $5.11 Million
Q2 2017 Aug 14, 2017	BUY	N/A	97,526	97,526 $5.76 Million

Others Institutions Holding PPH

# of Institutions

148

Shares Held

6.03M

Call Options Held

14.5K

Put Options Held

50.1K

View Full List

About VANECK ETF TR VANECK PHARMACEU

Ticker PPH
Sector ETFs
Industry ETFs

More about PPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Vaneck ETF Tr Vaneck Pharmaceu Transaction History